One of the main features of AD is cognitive decline, primarily due to neuronal loss caused by the progressive accumulation of Aβ42.[41] To determine whether the CRISPRa lipid nanocomplex targeting Mt3 could influence cognition‐related behaviors, we conducted behavioral assessments on 5xFAD mice. The gene discussed is MT3; the disease is Alzheimer disease.